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Abstract
Objectives—This study aimed to compare the prevalence and severity of pelvic floor symptoms 
and sexual function at 1 year postpartum in women who underwent either operative vaginal 
delivery (OVD) or cesarean delivery (CD) for second-stage arrest.
Methods—In this cohort study, women with second-stage arrest in their first pregnancy who 
delivered between January 2009 and May 2011 at 2 different institutions were identified by an 
obstetric database using International Classification of Diseases, Ninth Revision, codes. Validated 
questionnaires evaluating pelvic floor symptoms and sexual function were administered. Subjects 
were dichotomized into those who underwent an OVD or a CD. Additional analyses by intent-to-
treat and stratification of vacuum versus forceps operative deliveries were performed.
Results—Of the 109 women who completed the 1-year postpartum symptom questionnaires, 53 
(48.6%) had a successful OVD, 20 (18.3%) failed OVD and underwent CD, and 36 (33%) 
underwent CD only. There were no differences between those who had a successful OVD and 
those who underwent a CD in either pelvic floor function or sexual function, but bulge symptoms 
were more common in the OVD group (7.5% vs 0, P = 0.05). When analyzed by intent-to-treat 
(planned OVD vs planned CD), pelvic floor symptoms remained similar between groups. 
However, those in the planned CD group reported higher orgasm and overall sexual satisfaction 
scores.
Conclusions—In this sample of primiparous women with second-stage arrest, mode of delivery 
did not significantly impact pelvic floor function 1 year after delivery, except for bulge symptoms 
in the OVD group and sexual satisfaction in the planned CD group.
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The American Congress of Obstetricians and Gynecologists has defined a prolonged second 
stage of labor in nulliparous women as the lack of continuing progress for 3 hours with 
regional anesthesia or 2 hours without regional anesthesia.1 It occurs in 11% of nulliparous 
women.2 A prolonged second stage has been associated with a higher rate of maternal 
morbidity including perineal trauma, episiotomy, major hemorrhage during cesarean 
delivery (CD), and operative vaginal delivery (OVD).3 The rates of OVD range from 5% to 
20% of all births in industrialized countries,4,5 with second-stage arrest accounting for 
approximately 79%.4 A recent cohort study by Allen et al6 concluded that many of the 
increased risks of a prolonged second stage of labor were independent of the method of 
delivery.
The optimal management of second-stage arrest of labor presents a challenge to most 
obstetricians. The relative risks and benefits of maternal and fetal outcomes for a trial of 
OVD versus CD are not clearly defined and are difficult to study prospectively. Vaginal 
delivery has been shown to have a negative impact on urinary incontinence, fecal 
incontinence, and pelvic organ prolapse compared with CD,7–10 with a significantly higher 
prevalence of these disorders with OVD.7,11 However, the risk of OVD compared with CD 
for women with second-stage arrest has only been reported in a single European trial by 
Liebling et al.12 Randomized trials comparing OVD to immediate CD for women with 
second-stage arrest are lacking5 but are also very challenging to conduct. The incident risk 
of pelvic floor disorders in this population could be attributed to events that occurred before 
delivery, such as prolonged pressure on the pelvic floor causing stretch and denervation 
injuries, or to the delivery itself. Although there is a paucity of data regarding the impact of 
mode of delivery on pelvic floor disorders in these women, even less is known about 
potential differences in sexual function.
The objectives of our study were to evaluate and to compare pelvic floor and sexual function 
at 1 year postpartum in women with second-stage arrest in their first delivery who 
underwent a trial of OVD versus CD. Symptoms of pelvic organ prolapse and sexual 
dysfunction, in particular, have not been reported in prior studies. In addition, the 
differences in pelvic floor and sexual symptoms between vacuum and forceps OVD and the 
potential effect of breastfeeding as a confounding variable were assessed.
MATERIALS AND METHODS
Institutional review board approval was obtained at the University of North Carolina at 
Chapel Hill (UNC) and Carolinas Medical Center—Charlotte main campus (CMC) for this 
cohort study. Women who delivered between January 2009 and May 2011 were identified 
by an obstetric database using International Classification of Diseases, Ninth Revision, 
codes. Eligible subjects were contacted for study participation and screened via telephone. 
Inclusion criteria were primiparous women 18 years or older with term cephalic pregnancies 
and confirmation of second stage of labor greater than 2 hours. Exclusion criteria were 
multiple gestations, pregnancies with fetal anomalies, being a non-English speaker, and 
being pregnant again at 1 year postpartum. A second stage of labor greater than 2 hours was 
established by chart review and confirmed by patient recollection before enrollment.
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Subjects completed the telephone-validated Pelvic Floor Distress Inventory Short Form 
(PFDI-20)13 and the Female Sexual Function Index (FSFI).14 The PFDI-20 scores range 
from 0 to 300, and its pelvic organ prolapse subscale (POPDI-6), its colorectalanal subscale 
(CRADI-8), and urinary subscale (UDI-6) scores range from 0 to 100.15 Higher scores 
indicate more dysfunction. Rates of urinary incontinence, anal incontinence, and prolapse 
symptoms were established by responses to the specific corresponding questions in this 
questionnaire. Pain symptoms were elucidated by evaluating responses to question 1 of the 
POPDI-6, “Do you usually experience pressure in the lower abdomen?,” and question 6 of 
the UDI-6, “Do you usually experience pain or discomfort in the lower abdomen or genital 
region?” Bothersome symptoms were defined as a response of “somewhat,” “moderately,” 
or “quite a bit” bothersome. The FSFI is a non–condition-specific validated questionnaire 
that has 6 domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. Higher scores 
indicate better sexual function. An FSFI total score of 26.55 has been set as a cutoff score 
for determining sexual dysfunction.16 Women were also asked if they breastfed and for how 
long.
Demographics and delivery details were extracted from the electronic medical record: age, 
race, gestational age at index delivery, birth weight, fetal head presentation, station, Apgar 
scores, mode of delivery, type of labor (spontaneous or induced), presence of 
chorioamnionitis, degree and type of laceration, and length of hospital stay. Chart review 
was performed to confirm a second stage of labor greater than 2 hours. Subjects who did not 
meet these criteria were excluded.
Subjects were dichotomized into 2 groups: those who underwent a successful OVD (group 
1) and those who underwent a CD (including failed OVD, group 2). Because we cannot 
predict whether those opting for OVD will be successful, we ran an intent-to-treat analysis 
(planned OVD included successful and failed OVD vs planned CD) to assess those planning 
for OVD versus those planning for immediate CD. Furthermore, stratification of vacuum 
versus forceps operative deliveries was performed.
A 2 1/2–year enrollment period was set to recruit subjects for this descriptive study. 
Statistical analyses were performed with SPSS, version 19.0 (Chicago, Ill) including 
Pearson χ2 and Fisher exact test for categorical data and Student t test for continuous data.
RESULTS
There were 381 primiparous women with prolonged second stage based on provider coding. 
Based on chart review and patient recollection, 35 women were excluded because they did 
not actually have a prolonged second stage. After recruitment, an additional 9 women were 
excluded based on chart review because their second stage of labor was less than 120 
minutes. Ultimately, there were 337 primiparous women with prolonged second stage who 
met inclusion criteria based on provider coding, patient recollection, and chart review during 
this period. Of these, 137 could not be contacted, 22 declined, and 69 were excluded because 
of multiple gestations, they were non-English speakers, or they were pregnant at the time of 
assessment. The UNC was responsible for 90% of participants, and CMC was responsible 
for the remaining 10% of participants. Of the 109 women who completed the 1-year 
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postpartum symptom questionnaires, 53 (48.6%) had a successful OVD, 20 (18.3%) failed 
OVD and underwent CD, and 36 (33%) underwent CD only. The proportions of women 
delivered by OVD and CD were not similar between the 2 institutions (UNC, 53% vs 47%; 
CMC, 10% vs 90%). Baseline demographics were similar between successful OVD and CD, 
but there were differences in delivery characteristics (Table 1). Those who underwent a CD 
had a higher birth weight, more non-occiput anterior presentation, higher station at time of 
arrest, more chorioamnionitis, and a longer hospital stay.
Overall pelvic floor dysfunction was low with the mean PFDI-20 score of 23.9 in the OVD 
group and 20.3 in the CD group. There were no differences between OVD versus CD groups 
in sexual function by FSFI scores. When analyzed by intent-to-treat, results remained 
similar between groups. However, the planned CD group reported higher orgasm scores 
(4.52 vs 3.78, P = 0.05) and overall sexual satisfaction scores (4.70 vs 4.16, P = 0.044) than 
the planned OVD group.
Specific pelvic floor symptoms were elicited at 1-year postpartum. Any urinary incontinence 
was reported in 39.4% of our sample. There was no difference based on mode of delivery. 
The rate of stress urinary incontinence was 24.8%, with 19.3% of women reporting 
bothersome stress incontinence. The rate of urge urinary incontinence was 21.2%, with 
15.6% of women reporting bothersome urge incontinence. Any anal incontinence was 
reported in 24% of our sample. There was no difference based on mode of delivery. Flatal 
incontinence was reported in 17.4%, and loss of liquid or solid stool was reported in 9.2%. 
Bulge symptoms were reported in 3.7% of our sample. All women with postpartum bulge 
symptoms had undergone an OVD. Thus, bulge symptoms were more common in the OVD 
group compared with the CD group (7.5% vs 0%, P = 0.05). Sexual dysfunction, defined as 
an FSFI score of less than 26.55, was reported in 47% of the sample. There was no 
difference based on mode of delivery.
We then performed a subanalysis of the vacuum versus forceps deliveries. In the successful 
OVD group, there were 37 (69.8%) vacuum-assisted and 16 (30.2%) forceps-assisted 
deliveries. There was no difference in delivery characteristics between these 2 groups. There 
were 15 (28.3%) third- or fourth-degree perineal lacerations in the successful OVD group, 
with no difference between vacuum and forceps (27.0% vs 31.3%, P = 0.751). There were 
no differences in the rate of urinary, bowel, or sexual dysfunction symptoms between 
forceps and vacuum. However, women who underwent a forceps-assisted delivery had more 
prolapse symptoms based on POPDI-6 scores (8.85 vs 2.82, P = 0.05) and significantly 
higher rates of pressure and pain in the lower abdomen and vagina at 1 year postpartum 
(25% vs 2.7%, P = 0.025). A forceps-assisted delivery was associated with more than a 9-
fold higher risk of lower abdominal pressure compared with vacuum-assisted delivery 
(relative risk, 9.3; confidence interval, 1.1–76.4; P = 0.025). This was also consistent in 
those analyzed by intent-to-treat with forceps-assisted attempts having higher rates of pain 
or discomfort in the lower abdomen or genital region compared with the vacuum-assisted 
attempts (18.2% vs 2.0%, P = 0.027).
Of the 108 subjects who discussed breastfeeding, 57.4% breastfed for 6 months or more. 
The rate of breastfeeding was not different between OVD and CD groups. Those who 
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reported breastfeeding for greater than 6 months had less dyspareunia overall (4.77 vs 4.02, 
P = 0.05).
DISCUSSION
In women with second-stage arrest in their first pregnancy, mode of delivery did not 
significantly impact pelvic floor function 1 year after delivery. Notable differences in pelvic 
floor symptoms between the 2 groups included more vaginal bulge symptoms in the OVD 
group, with lower orgasm and sexual satisfaction scores in the planned OVD group (intent-
to-treat analysis). Variables associated with successful OVD included lower infant birth 
weight, lower station, absence of chorioamnionitis, and an occiput anterior head position.
Despite the potential for pelvic floor injury in this high-risk population, overall subjective 
complaints of pelvic floor dysfunction, as measured by the PFDI-20, were low. This 
questionnaire was validated in symptomatic older women in whom the mean score before 
treatment was 121.6 and the mean score after treatment was 50.215 as compared with mean 
scores of 23.9 and 20.3 in the OVD and CD groups, respectively. It is possible that subtle 
differences in pelvic floor symptoms between groups were not effectively measured using 
this instrument.
Urinary incontinence was the most prevalent pelvic floor disorder in our population at 
39.4%, with bothersome urge and stress incontinence symptoms in 15% to 19% of our 
sample. Having a CD for the indication of second-stage arrest was not protective against 
this. Although OVD has been consistently identified as a significant and major risk factor 
for both stress and urge incontinence when compared with CD,7,10,17 these studies did not 
selectively evaluate women with second-stage arrest, a population in whom pelvic floor 
injury may have preceded delivery. In the one existing prospective cohort study of women 
requiring operative delivery at full dilation, Liebling et al12 did find that OVD was 
associated with a greater risk of urinary incontinence at 6 weeks (odds ratio, 7.8) compared 
with immediate CD. By 1 year postpartum, however, this had declined to a 3-fold increased 
risk.12 Similarly, in a study of women 6 years after index delivery, persistent urinary 
incontinence was not higher in women with OVD.18
Although flatal incontinence was reported by 17.4% of our cohort, the rate of any fecal 
incontinence was 9.2%. Despite a 28% rate of anal sphincter lacerations in the OVD group, 
rates of anal incontinence were not significantly different between women delivered by 
OVD versus CD, a finding corroborated by Liebling et al.12 The Childbirth and Pelvic 
Symptoms study found that women with sphincter tears reported more fecal incontinence 
and greater severity at both 6 weeks and 6 months postpartum, but this again was not 
compared with women undergoing CD for second-stage arrest.9 Despite anal sphincter tears 
potentially serving as a proxy for more extensive pelvic floor injury, we observed no 
differences in pelvic floor or sexual symptoms in those that sustained these tears and those 
who did not. This is consistent with the findings of Brown et al,19 who reported that OVD as 
compared with CD did not significantly alter the likelihood of fecal incontinence beyond the 
first 3 months postpartum.
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The prevalence of pelvic organ prolapse has not been reported in women with a diagnosis of 
second-stage arrest, regardless of mode of delivery. In our cohort, we observed a higher rate 
of bulge symptoms in the OVD group that very likely is due to higher rates of levator ani 
injury in this group. A recent study that compared the differences in levator ani injury on 
magnetic resonance imaging in women with forceps delivery for fetal distress, forceps 
delivery for second-stage arrest, and spontaneous delivery found that major defects were 
seen in 42%, 63%, and 6%, respectively, implicating forceps, not delivery itself, as the 
affecting variable.20 Handa et al7 reported a significant association between OVD and 
prolapse in their epidemiologic study with the odds of having prolapse being over 7-fold in 
those who had at least 1 OVD. Those who had a forceps-assisted OVD had significantly 
higher rates of prolapse symptoms compared with those who had a vacuum-assisted OVD.
Women who undergo OVD are more likely to sustain a severe perineal laceration that may 
be associated with dyspareunia and an altered perception of vaginal anatomy than women 
delivered by CD. As a result, sexual function is an essential factor that requires evaluation. 
We found that women who underwent a planned, or immediate, CD at the time of second-
stage arrest had higher orgasm and sexual satisfaction scores than those in the planned OVD 
group. Perhaps women who failed an operative delivery had increased pelvic floor 
neuromuscular trauma compared with women who did not attempt an operative delivery or 
those with a successful operative delivery. However, this is only postulation.
The limitations of this study are the inherent biases of a retrospective cohort design, 
relatively small sample size, un-blinded interviewers who were often informed of the 
delivery method by the study subject, and lack of objective clinical examination at 1 year 
postpartum. A post hoc power calculation was performed based on the study of Liebling et 
al that reported urinary incontinence rate of 17% in the OVD group and 5.4% in the CD 
group at 1 year postpartum, and our sample was underpowered for this at 47%. Our 
recruitment was limited by the rate of second pregnancy in the potential study subjects. 
Thus, we set a 2 1/2-year period for study enrollment. Selection and reporting bias may have 
affected the observed rates of pelvic floor disorders and sexual dysfunction. Those who 
participated may have been more interested in the study because of the nature of their 
delivery and their current symptoms.
The strengths of this study include the use of validated pelvic floor and sexual symptom 
questionnaires, a significant difference between our study and that of Liebling et al,12 the 1 
year follow up, and the inclusion of 2 study sites, which could improve the generalizability 
of the results. In addition, the use of a strict definition for second-stage arrest that was 
established by provider coding and confirmed by chart review and patient recollection offers 
an accurate sample for women who underwent second-stage arrest.
In conclusion, we found that, in women with second-stage arrest, OVD was not associated 
with increased rates of pelvic floor symptoms at 1 year postpartum compared with CD 
except for bulge symptoms. The difficult choice of how to proceed in this circumstance 
should not be influenced by the notion that CD is protective of the pelvic floor in these 
women. Specific elements of sexual function, however, may be improved with immediate 
CD. Although the long-term implications of these delivery choices are not known, the 
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findings that we elicited at 1 year postpartum may be useful when counseling women with 
second-stage arrest.
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TABLE 1
Baseline Demographics and Delivery Characteristics
Demographics Group 1 (Successful OVD), n = 53 Group 2 (Underwent CD), n = 56 P
Age, mean(SD), y 28.8 (5.7) 29.5 (5.0) 0.48*
Race, n (%)
 White 43 (81) 44 (79) 0.95†
 African American 5 (9) 4 (7)
 Hispanic 1 (2) 2 (4)
 Asian 3 (6) 5 (9)
 Other 1 (2) 1 (2)
Gestational age at delivery, mean (SD), wk 39.9 (1.1) 40.0 (1.3) 0.84*
Type of labor, n (%)
 Spontaneous 16 (30) 12 (21) 0.63†
 Spontaneous with augmentation 23 (43) 27 (48)
 Induced 14 (26) 16 (29)
Fetal head presentation, n (%) n = 42 n = 29
 OA 30 (71) 25 (86) <0.01‡
 Non-OA 12 (29) 4 (14)
Station, n (%) n = 49 n = 42
 ≥+2 47 (96) 18 (43) <0.01‡
 <+2 2 (4) 24 (57)
Time in second-stage arrest, mean (SD), min 192 (40) 178 (50) 0.15*
Birth weight, mean (SD), g 3394 (461) 3641 (576) 0.02*
Apgars, mean (SD)
 1 min 7.1 (2.0) 6.9 (2.8) 0.66*
 5 min 8.7 (0.7) 8.5 (1.3) 0.38*
Chorioamnionitis, n (%) 4 (7.5) 16 (28.6) 0.01‡
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